42/120
1.8 / 5 stars
All 120 Win/Lose results shown below
SRTS Roast Me summary
Sensus Healthcare, Inc. (SRTS). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 24 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseSRTS / S&P -24.12% / 15.20% |
LoseSRTS / S&P -53.39% / 15.00% |
LoseSRTS / S&P SRTS unavailable / 50.40% |
| 2026-Q11/3 |
WinSRTS / S&P 0.00% / -4.33% |
LoseSRTS / S&P -42.94% / 11.30% |
LoseSRTS / S&P -527.27% / 27.70% |
| 2025-Q41/3 |
WinSRTS / S&P 26.75% / 2.65% |
LoseSRTS / S&P -34.26% / 9.00% |
LoseSRTS / S&P -214.63% / 13.40% |
| 2025-Q30/3 |
LoseSRTS / S&P -33.76% / 8.12% |
LoseSRTS / S&P -13.80% / 4.61% |
LoseSRTS / S&P -131.58% / 13.45% |
| 2025-Q20/3 |
LoseSRTS / S&P 0.21% / 10.94% |
LoseSRTS / S&P 3.29% / 4.83% |
LoseSRTS / S&P -112.20% / 10.63% |
| 2025-Q11/3 |
LoseSRTS / S&P -31.65% / -4.27% |
WinSRTS / S&P 24.74% / 4.98% |
LoseSRTS / S&P -62.07% / 10.57% |
| 2024-Q43/3 |
WinSRTS / S&P 19.31% / 2.41% |
WinSRTS / S&P 71.31% / 5.25% |
WinSRTS / S&P 1266.67% / 6.15% |
| 2024-Q32/3 |
WinSRTS / S&P 8.82% / 5.89% |
WinSRTS / S&P 65.61% / 5.89% |
LoseSRTS / S&P SRTS unavailable / 6.11% |
| 2024-Q23/3 |
WinSRTS / S&P 40.26% / 4.28% |
WinSRTS / S&P 21.00% / 5.38% |
WinSRTS / S&P 173.33% / 5.12% |
| 2024-Q11/3 |
WinSRTS / S&P 61.02% / 10.56% |
LoseSRTS / S&P -15.83% / 5.71% |
LoseSRTS / S&P -23.68% / 5.59% |
| 2023-Q40/3 |
LoseSRTS / S&P -14.80% / 11.69% |
LoseSRTS / S&P -45.20% / 6.81% |
LoseSRTS / S&P -97.95% / 7.78% |
| 2023-Q30/3 |
LoseSRTS / S&P -12.06% / -3.27% |
LoseSRTS / S&P -43.89% / 7.52% |
LoseSRTS / S&P -103.11% / -5.03% |
| 2023-Q20/3 |
LoseSRTS / S&P -39.54% / 8.74% |
LoseSRTS / S&P -26.64% / 9.50% |
LoseSRTS / S&P -90.07% / -8.57% |
| 2023-Q10/3 |
LoseSRTS / S&P -29.78% / 7.50% |
LoseSRTS / S&P 9.61% / 10.77% |
LoseSRTS / S&P -70.31% / -15.69% |
| 2022-Q42/3 |
LoseSRTS / S&P -40.78% / 7.56% |
WinSRTS / S&P 64.68% / 11.88% |
WinSRTS / S&P 484.00% / -17.99% |
| 2022-Q32/3 |
WinSRTS / S&P 63.15% / -4.88% |
WinSRTS / S&P 132.60% / 13.47% |
LoseSRTS / S&P SRTS unavailable / -1.41% |
| 2022-Q21/3 |
LoseSRTS / S&P -24.11% / -16.10% |
WinSRTS / S&P 169.41% / 13.71% |
LoseSRTS / S&P SRTS unavailable / 11.04% |
| 2022-Q12/3 |
WinSRTS / S&P 40.17% / -4.60% |
WinSRTS / S&P 212.83% / 15.97% |
LoseSRTS / S&P SRTS unavailable / 42.23% |
| 2021-Q42/3 |
WinSRTS / S&P 100.56% / 11.03% |
WinSRTS / S&P 182.36% / 15.00% |
LoseSRTS / S&P SRTS unavailable / 96.40% |
| 2021-Q31/3 |
LoseSRTS / S&P -6.49% / 0.58% |
WinSRTS / S&P 47.11% / 10.77% |
LoseSRTS / S&P SRTS unavailable / 69.42% |
| 2021-Q20/3 |
LoseSRTS / S&P 0.52% / 8.55% |
LoseSRTS / S&P -11.65% / 6.58% |
LoseSRTS / S&P SRTS unavailable / 51.81% |
| 2021-Q10/3 |
LoseSRTS / S&P -0.78% / 6.17% |
LoseSRTS / S&P -53.34% / -1.06% |
LoseSRTS / S&P SRTS unavailable / 7.39% |
| 2020-Q41/3 |
WinSRTS / S&P 53.17% / 12.15% |
LoseSRTS / S&P -64.87% / -3.72% |
LoseSRTS / S&P SRTS unavailable / -33.42% |
| 2020-Q30/3 |
LoseSRTS / S&P -17.65% / 8.93% |
LoseSRTS / S&P -51.59% / -2.04% |
LoseSRTS / S&P SRTS unavailable / -27.10% |
| 2020-Q21/3 |
WinSRTS / S&P 22.40% / 20.54% |
LoseSRTS / S&P -37.02% / -0.46% |
LoseSRTS / S&P SRTS unavailable / -27.11% |
| 2020-Q10/3 |
LoseSRTS / S&P -29.38% / -19.60% |
LoseSRTS / S&P -9.27% / 3.47% |
LoseSRTS / S&P SRTS unavailable / -14.75% |
| 2019-Q40/3 |
LoseSRTS / S&P -41.00% / 9.07% |
LoseSRTS / S&P 3.16% / 5.36% |
LoseSRTS / S&P SRTS unavailable / 2.99% |
| 2019-Q32/3 |
WinSRTS / S&P 8.30% / 1.70% |
WinSRTS / S&P 8.14% / 5.02% |
LoseSRTS / S&P SRTS unavailable / 0.21% |
| 2019-Q21/3 |
LoseSRTS / S&P -21.08% / 4.30% |
WinSRTS / S&P 17.40% / 6.64% |
LoseSRTS / S&P SRTS unavailable / 8.65% |
| 2019-Q11/3 |
LoseSRTS / S&P -5.26% / 13.65% |
WinSRTS / S&P 16.76% / 8.12% |
LoseSRTS / S&P SRTS unavailable / 14.29% |
| 2018-Q42/3 |
WinSRTS / S&P -11.58% / -13.52% |
WinSRTS / S&P 28.36% / 9.05% |
LoseSRTS / S&P SRTS unavailable / 18.23% |
| 2018-Q32/3 |
WinSRTS / S&P 15.43% / 7.71% |
WinSRTS / S&P 30.64% / 10.21% |
LoseSRTS / S&P SRTS unavailable / 19.06% |
| 2018-Q22/3 |
WinSRTS / S&P 24.32% / 3.43% |
WinSRTS / S&P 32.81% / 9.03% |
LoseSRTS / S&P SRTS unavailable / 14.46% |
| 2018-Q12/3 |
WinSRTS / S&P 13.18% / -0.76% |
WinSRTS / S&P 37.56% / 7.68% |
LoseSRTS / S&P SRTS unavailable / 12.46% |
| 2017-Q41/3 |
LoseSRTS / S&P 3.61% / 6.64% |
WinSRTS / S&P 39.00% / 7.03% |
LoseSRTS / S&P SRTS unavailable / 13.82% |
| 2017-Q32/3 |
WinSRTS / S&P 23.88% / 4.48% |
WinSRTS / S&P 37.90% / 5.68% |
LoseSRTS / S&P SRTS unavailable / 17.57% |
| 2017-Q21/3 |
LoseSRTS / S&P -8.43% / 3.09% |
WinSRTS / S&P 39.61% / 4.83% |
LoseSRTS / S&P SRTS unavailable / 17.74% |
| 2017-Q11/3 |
LoseSRTS / S&P -16.38% / 6.07% |
WinSRTS / S&P 41.76% / 3.67% |
LoseSRTS / S&P SRTS unavailable / 13.32% |
| 2016-Q41/3 |
LoseSRTS / S&P -14.63% / 3.82% |
WinSRTS / S&P 44.17% / 2.09% |
LoseSRTS / S&P SRTS unavailable / 7.05% |
| 2016-Q30/3 |
LoseSRTS / S&P SRTS unavailable / 3.85% |
LoseSRTS / S&P SRTS unavailable / 0.20% |
LoseSRTS / S&P SRTS unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | SRTS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 3.18% | 20.78% |
| Annualized return | 3.18% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | SRTS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -2.57% | 83.14% |
| Annualized return | -0.52% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | SRTS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -44.48% | 319.30% |
| Annualized return | -5.71% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-24.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B |